EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries

Mohammed Gebre Dedefo iD, Gizat M Kassie, Eyob Alemayehu Gebreyohannes iD, Renly Lim, Elizabeth Roughead iD, Lisa Kalisch Ellett iD

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70164 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Mohammed Gebre Dedefo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Drug Industry, Health Personnel, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of South Australia, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assessed whether the completeness of spontaneously reported adverse drug reaction (ADR) reports differs between consumers and healthcare professionals when submitted directly to regulators, and how this compares to reports from pharmaceutical companies. ADR reports (2014–2023) were obtained from public databases in Canada and the United Kingdom (UK), focusing on the medicine classes sodium‐glucose cotransporter 2 inhibitors, glucagon‐like peptide 1 receptor agonists, and dipeptidyl peptidase‐4 inhibitors. ADR report completeness was assessed using vigiGrade tool variables. Descriptive statistics and chi‐square tests were used for analysis. A total of 17 897 reports were analyzed—13 613 from the UK Yellow Card Scheme and 4284 from Canada. Most Canadian reports were submitted by pharmaceutical companies (55%), while in the UK, healthcare professionals submitted the majority (69%). Few reports were submitted directly by consumers in either Canada (4%) or the UK (7%). In Canada, the average completeness was 82% for consumer and healthcare professional reports and 57% for pharmaceutical companies. In the UK, completeness was 80% (consumers), 82% (healthcare professionals), and 69% (pharmaceutical companies). Canadian pharmaceutical company reports were significantly less complete for age, sex, outcome, dose, indication, and route of administration (all p < 0.001). In the UK, they were less complete for age, sex, and route of administration (all p < 0.001). In conclusion, reports submitted directly to regulators by consumers and healthcare professionals were more complete than those from pharmaceutical companies. The low consumer reporting rate, yet high completeness rate, highlights the need to encourage direct reporting to regulators to improve medicine safety monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsDrug IndustryHealth PersonnelDrug-Related Side Effects and Adverse ReactionsHumansCanadaUnited KingdomDatabases, FactualMaleFemaleAdultMiddle AgedPharmacovigilanceAdolescentYoung AdultDipeptidyl-Peptidase IV InhibitorsAged

Stichwörter der Autor:innen

adverse drug reaction reporting systemsdrug monitoringdrug safetydrug‐related side effects and adverse reactionspharmacovigilance

Substanzen

Dipeptidyl-Peptidase IV Inhibitors

Autor:innen und Institutionen

  • Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia.
  • South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Centre for Optimisation of Medicines, School of Allied Health, The University of Western Australia, Perth, Australia.

ORCID-Profile: Mohammed Gebre Dedefo, Eyob Alemayehu Gebreyohannes, Elizabeth Roughead, Lisa Kalisch Ellett

Förderung

  • University of South Australia
  • National Health and Medical Research Council

Zitieren

APA

Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Kalisch Ellett, L. (2025). Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70164

Vancouver

Dedefo MG, Kassie GM, Gebreyohannes EA, Lim R, Roughead E, Kalisch Ellett L. Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70164

BibTeX
@article{Dedefo2025,
  author = {Dedefo, Mohammed Gebre and Kassie, Gizat M and Gebreyohannes, Eyob Alemayehu and Lim, Renly and Roughead, Elizabeth and Kalisch Ellett, Lisa},
  title = {Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70164}
}
Kostenlos starten →